When Curtain Falls: 4+7 To 4+N Signals End To Branded Generics In China?
Executive Summary
After only two multinationals managed to win bids in China's massive new centralized drug procurement scheme, other foreign firms were hoping to get a break in the second round. But this may not materialize.